Minerva Neurosciences (NERV) Gains on Positive Results from Sleep Disorder Study
Tweet Send to a Friend
Minerva Neurosciences, Inc. (Nasdaq: NERV) is up 15.9% after-hours Wednesday after the company announced that preliminary results from a Phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
